Hans Guski

CD24 expression is a new prognostic marker in breast cancer.

Glen Kristiansen, Klaus‐Jürgen Winzer, Émpar Mayordomo et al. · PubMed · 2003 · 307 citations

Medicine, Oncology, Pathology +17

Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

Carsten Denkert, Klaus‐Jürgen Winzer, B. Müller et al. · Cancer · 2003 · 250 citations · Full text

Medicine, Cancer Biology, Oncology +13

Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.

Ralf C. Bargou, Christian Wagener, Kurt Bommert et al. · Journal of Clinical Investigation · 1996 · 191 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Expression of the ELAV-Like Protein HuR Is Associated with Higher Tumor Grade and Increased Cyclooxygenase-2 Expression in Human Breast Carcinoma

Carsten Denkert, Wilko Weichert, Klaus‐Jürgen Winzer et al. · Clinical Cancer Research · 2004 · 151 citations · Full text

Medicine, Molecular Biology, Oncology +14

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence

Klaus‐Jürgen Winzer, Willi Sauerbrei, Manfred Braun et al. · European Journal of Cancer · 2009 · 150 citations

Medicine, Oncology, Surgery +15